SciSparc (SPRC) Competitors $0.31 0.00 (-0.99%) Closing price 03/27/2025 03:55 PM EasternExtended Trading$0.32 +0.01 (+1.86%) As of 03/27/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SPRC vs. HCWB, IPA, CTXR, ATHA, BMRA, NERV, ORGS, FLGC, CING, and GOVXShould you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include HCW Biologics (HCWB), ImmunoPrecise Antibodies (IPA), Citius Pharmaceuticals (CTXR), Athira Pharma (ATHA), Biomerica (BMRA), Minerva Neurosciences (NERV), Orgenesis (ORGS), Flora Growth (FLGC), Cingulate (CING), and GeoVax Labs (GOVX). These companies are all part of the "pharmaceutical products" industry. SciSparc vs. HCW Biologics ImmunoPrecise Antibodies Citius Pharmaceuticals Athira Pharma Biomerica Minerva Neurosciences Orgenesis Flora Growth Cingulate GeoVax Labs SciSparc (NASDAQ:SPRC) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, community ranking, media sentiment and analyst recommendations. Which has preferable earnings and valuation, SPRC or HCWB? SciSparc has higher earnings, but lower revenue than HCW Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSciSparc$1.75M1.84-$5.12MN/AN/AHCW Biologics$3.50M3.85-$24.99M-$1.00-0.30 Is SPRC or HCWB more profitable? SciSparc has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. SciSparc's return on equity of 0.00% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets SciSparcN/A N/A N/A HCW Biologics -1,067.82%-2,516.84%-132.95% Does the MarketBeat Community believe in SPRC or HCWB? HCW Biologics received 4 more outperform votes than SciSparc when rated by MarketBeat users. Likewise, 100.00% of users gave HCW Biologics an outperform vote while only 66.67% of users gave SciSparc an outperform vote. CompanyUnderperformOutperformSciSparcOutperform Votes266.67% Underperform Votes133.33% HCW BiologicsOutperform Votes6100.00% Underperform VotesNo Votes Do institutionals and insiders believe in SPRC or HCWB? 25.1% of SciSparc shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 1.5% of SciSparc shares are held by insiders. Comparatively, 49.9% of HCW Biologics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer SPRC or HCWB? In the previous week, SciSparc had 2 more articles in the media than HCW Biologics. MarketBeat recorded 4 mentions for SciSparc and 2 mentions for HCW Biologics. HCW Biologics' average media sentiment score of 1.44 beat SciSparc's score of 0.53 indicating that HCW Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SciSparc 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HCW Biologics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, SPRC or HCWB? SciSparc has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. SummaryHCW Biologics beats SciSparc on 7 of the 13 factors compared between the two stocks. Remove Ads Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPRC vs. The Competition Export to ExcelMetricSciSparcPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.22M$6.91B$5.64B$8.06BDividend YieldN/A2.73%4.56%4.02%P/E RatioN/A7.2023.1319.03Price / Sales1.84226.01383.8993.17Price / CashN/A65.6738.1634.64Price / Book0.026.476.944.33Net Income-$5.12M$141.90M$3.20B$247.06M7 Day Performance-8.20%-3.05%-2.30%-0.52%1 Month Performance-15.73%-4.63%3.10%-3.73%1 Year Performance-82.11%-8.61%11.22%1.74% SciSparc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPRCSciSparc0.3669 of 5 stars$0.31-1.0%N/A-82.1%$3.22M$1.75M0.004Short Interest ↑Gap DownHCWBHCW Biologics1.9235 of 5 stars$0.30-1.2%N/A-82.8%$13.36M$3.50M-0.3040Positive NewsIPAImmunoPrecise Antibodies2.3285 of 5 stars$0.43+1.6%$5.00+1,062.8%-72.0%$13.36M$24.07M-0.5580Short Interest ↑Gap DownCTXRCitius Pharmaceuticals3.3436 of 5 stars$1.55+2.0%$54.50+3,416.1%-93.7%$13.32MN/A0.0020Positive NewsATHAAthira Pharma2.5568 of 5 stars$0.34+2.4%$13.83+3,968.6%-88.2%$13.27MN/A-0.1240Positive NewsGap UpBMRABiomerica1.0108 of 5 stars$0.71+3.6%N/A-30.4%$13.02M$5.58M-2.0960Short Interest ↓News CoveragePositive NewsNERVMinerva Neurosciences3.7516 of 5 stars$1.85+2.8%$5.00+170.3%-28.2%$12.94MN/A-4.209Analyst ForecastShort Interest ↓News CoverageORGSOrgenesisN/A$2.69-4.0%N/AN/A$12.91M$662,000.000.00150Gap UpFLGCFlora Growth3.2491 of 5 stars$0.66+5.9%$5.00+661.3%-70.0%$12.77M$64.15M0.00280Earnings ReportShort Interest ↓CINGCingulate3.2126 of 5 stars$3.94-0.5%$16.00+306.1%+299.1%$12.66MN/A0.0020Short Interest ↓GOVXGeoVax Labs3.084 of 5 stars$1.40+6.9%$14.20+914.3%-31.4%$12.36M$3.09M0.0010Short Interest ↓News Coverage Remove Ads Related Companies and Tools Related Companies HCWB Alternatives IPA Alternatives CTXR Alternatives ATHA Alternatives BMRA Alternatives NERV Alternatives ORGS Alternatives FLGC Alternatives CING Alternatives GOVX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPRC) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SciSparc Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SciSparc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRC Stock Free SPRC Stock Alerts